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AbstrAct
Objectives To estimate cardiac rehabilitation (CR) referral 
and participation rates among patients with acute coronary 
syndrome (ACS) and to identify their determinants, in two 
Portuguese regions.
Design Prospective cohort study.
setting Patients consecutively admitted to the cardiology 
department of two hospitals, one in the district of Porto 
and one in the north-east region (NER) of Portugal, were 
enrolled in the EPIHeart cohort and then followed up for 
6 months.
Participants Between August 2013 and December 2014, 
939 patients were included in the cohort, and 853 were 
re-evaluated at 6-month follow-up.
Outcome measures Referral rate was defined as the 
proportion of eligible patients who were referred to a CR 
programme, whereas participation rate was defined as 
the proportion of eligible patients who completed a CR 
programme, as was recommended by their physicians.
results Patients referred were 32.3% and 10.7% of those 
eligible in Porto and NER, respectively. In both regions, 
referral to CR decreased with age and with longer travel 
times to CR centres and increased with education or social 
class. At follow-up, 128 patients from Porto (26.2% of 
those eligible and 81.0% of those referred) and 26 from 
NER (7.1% of those eligible and 66.7% of those referred) 
reported actually participating in a CR programme. In 
Porto, the main barriers to participation were the long time 
until a programme was available and lack of perceived 
benefit. Patients in NER identified distance to CR and costs 
as the main barriers.
conclusions CR remains clearly underused in Portugal, 
with major inequalities in access between regions. 
Achieving equitable and greater use of CR requires 
a multilevel approach addressing barriers related to 
healthcare system, providers and patients in order to 
improve provision, referral and participation.
IntrODuctIOn 
Cardiac rehabilitation (CR) programmes are 
currently recognised as an integral part of the 
approach for secondary prevention of coro-
nary heart disease (CHD) and considered a 
class I recommendation in current clinical 
guidelines by the American Heart Association, 
the American College of Cardiology and the 
European Society of Cardiology for treatment 
of patients with CHD.1–4 
A recent Cochrane systematic review showed 
that CR reduces cardiovascular mortality and 
hospitalisations while improving quality of 
life.5 This evidence was subsequently extended 
by a multicentre cohort of patients with acute 
myocardial infarction (AMI) showing that 
participation in CR was associated with 41% 
lower hazard of all-cause mortality.6 More-
over, CR has been described as a cost-effective 
intervention,7 8 with cost-effectiveness ratios 
similar to the use of angiotensin converting 
enzyme (ACE) inhibitors and statins.8
Despite the robust evidence supporting 
the use of CR, it clearly remains underused 
worldwide.9 In Portugal, the proportion of 
eligible patients enrolled in rehabilitation 
programmes has increased from 3% in 2007 
to 8% in 2013,10 11 though still far from the 
30% target set by the National Health Plan 
for 2010.12 The implementation of CR in 
Portugal is constrained by insufficient supply 
of CR services and large geographical dispar-
ities in their distribution, with CR centres 
concentrated mainly in large urban areas of 
the country.10 11 The aim of the present study 
was to estimate the proportion of patients 
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Research
strengths and limitations of this study
 ► This study assessed the frequency and 
determinants of referral and participation to cardiac 
rehabilitation (CR), among urban and rural settings.
 ► Identifying target groups and geographic areas 
where access is more limited is essential to establish 
clear strategies to reduce inequalities in the use of 
healthcare services.
 ► Our results may not be generalised to other settings 
with different characteristics, although the study 
was conducted in two hospitals attending patients 
with contrasting use of CR.
 o
n
 24 N
ovem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-018934 on 3 January 2018. Downloaded from 
2 Viana M, et al. BMJ Open 2018;8:e018934. doi:10.1136/bmjopen-2017-018934
Open Access 
Figure 1 EPIHeart cohort study setting. (A) Study area and location of the hospitals. (B) Travel times from patients’ home to 
the nearest cardiac rehabilitation centre.
with acute coronary syndrome (ACS) who were referred 
and who actually participated in a CR programme, 
comparing two regions in the north of Portugal. The 
work also intended to identify determinants of referral 
and to describe barriers to participation.
MethODs
setting
The present study evaluated patients with an ACS 
enrolled in the EPIHeart cohort, who were admitted to 
two hospitals (São João Hospital and São Pedro Hospital) 
in the north of mainland Portugal. São João Hospital is 
a university hospital located in the Porto municipality, 
which serves as first-line service part of the population 
of the Porto district (mainly coastal and urban), whereas 
São Pedro Hospital is a tertiary-level hospital located in 
the Vila Real municipality serving, as first-line or referral 
target, the population of the north-east region (NER) 
of Portugal (mainly rural and located in the inner 
land), which covers the districts of Vila Real, Bragança 
and some municipalities of the Viseu district. Since the 
EPIHeart cohort was set up to assess inequalities in CHD 
management and outcomes in urban and rural settings 
in Portugal, the selection of these regions intended to 
capture the variation in CHD management and outcomes 
across populations with different sociodemographic and 
clinical characteristics.
In the four districts considered in this study, there are 
eight CR centres available, seven in the Porto district 
and one in the NER.11 In the Porto district, there are 
four public centres, located within the facilities of public 
hospitals, and three private centres, located in privately 
owned healthcare organisations. In the Porto district, 
the first CR programme was implemented in 1992 in a 
private clinic, and the last one was implemented in 2008 
in São João Hospital. In the NER, there is only one private 
centre available, which was launched in 2012.
The location of the study area is depicted in figure 1A. 
study population
Between August 2013 and December 2014, patients 
consecutively admitted to the cardiology departments of 
the two hospitals involved in the study were enrolled in 
the EPIHeart cohort and then followed up for 6 months. 
Hospitalised patients were invited to participate in the 
study by trained staff nurses or physicians in charge, who 
gave written information, explained the study verbally 
and obtained written informed consent. The inclusion 
criteria were to be admitted with a diagnosis of ACS type 
I, aged ≥18 years, expected to have a length of stay longer 
than 48 hours and living inside the hospitals’ catchments 
area. Exclusion criteria were non-confirmed diagnosis of 
ACS, death, discharge or transfer prior to interview invi-
tation and inability to answer the questionnaires, due to 
clinical instability, no domain of Portuguese language, 
hearing problems or cognitive impairment, as evaluated 
by the interviewer. Of the 1297 patients initially consid-
ered, 286 were excluded, and 72 refused to participate 
(7.1% of those invited, 4% in the Porto district and 11% 
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in the NER), thus the final sample included 939 patients. 
Patients who refused to participate in the study were 
significantly older (72.7 years vs 64.2 years, P<0.001) and 
had lower education than those who participated (4 years 
of schooling or less: 59.4% vs 77.6%, P=0.003), whereas 
there was no significant difference in the ACS types 
(ST-segment elevation myocardial infarction (STEMI): 
37.1% vs 37.4%, P=0.961). At the 6-month follow-up, 51 
patients were dead, 18 patients were not evaluated due to 
invalid contact details and 17 refused to continue in the 
study, hence 853 patients were included in the current 
analysis. Non-participants in the follow-up were older 
(non-participants due to death: 75.3 years vs non-partici-
pants due to refusals and losses: 64.1 years vs participants: 
63.5 years, P<0.001) and had lower education (≤4 years of 
schooling) than those who participated (non-participants 
due to death: 82.6% vs participants due to refusals and 
losses: 71.9% vs participants: 57.7%, P<0.001).
The study protocol complied with the Declaration of 
Helsinki and was approved by the Ethics Committee of 
both hospitals involved.
Data collection
At baseline, a face-to-face interview was conducted by 
trained researchers to collect data about sociodemo-
graphic characteristics, and the patients’ medical records 
were reviewed to collect clinical data.
Sociodemographic data included age, sex, home 
address, marital status, health insurance coverage, subjec-
tive social class, schooling years, main activity, occupation 
and monthly household income. The marital status was 
considered partnered for married patients or living in 
civil union and unpartnered for patients who were single, 
separated, divorced or widow(er). Health insurance 
coverage comprised health subsystems and private health 
insurance. Subjective social class was assessed by asking 
patients to identify their social class category from a list 
provided, that included lower class, lower-middle class, 
upper-middle class and upper class. Occupations were 
classified into major professional groups, according to the 
Portuguese National Classification of Occupations 2010 
integrated in the International Standard Classification 
of Occupations 200813 14 and grouped into three catego-
ries: upper white collar (executive civil servants, indus-
trial directors and executives, professionals and scientists 
and middle management and technicians), lower white 
collar (administrative and related workers and service 
and sales workers) and blue collar (farmers and skilled 
agricultural, fisheries workers, skilled workers, craftsmen 
and similar, machine operators and assembly workers and 
unskilled workers). Armed forces were not considered for 
this classification. Retired, disabled and housewives were 
classified considering their previous main occupation, 
when applicable.
Clinical data included risk factors and comorbidities, 
clinical characteristics at admission, medical procedures, 
left ventricular systolic dysfunction (LVSD) and type of 
ACS. LVSD was considered present when there was a 
qualitative description consistent with moderate or severe 
systolic dysfunction in the last completed echocardiog-
raphy during the hospital stay. The type of ACS was used 
as clinically defined in discharge notes and classified as 
STEMI and non-ST-elevation ACS (NSTEACS), with the 
latter including unstable angina, non-ST-elevation AMI, 
subacute MI and non-classified ACS.
Six months after the index event, patients were contacted 
by telephone and asked whether they were referred to 
CR following the event and whether they attended the 
CR programme as was recommended by their physician. 
Patients who attended and completed the CR programme 
were asked to identify the CR centre and the number of 
sessions attended. Patients who did not attend or complete 
the programme were asked about the reasons for non-par-
ticipation, through the selection of one or more of the 
following options: (1) cost, (2) distance from home to the 
CR centre, (3) limited time availability, (4) lack of perceived 
benefit, (5) delay in enrolment in a CR programme due 
to lack of vacant places and (6) other reason. Referral 
rate was defined as the proportion of eligible patients who 
were referred to a CR programme, whereas participation 
rate was defined as the proportion of eligible patients who 
completed a CR programme, as was recommended by their 
physicians.
In order to compute travel time to the nearest CR centre, 
descriptive data about the available CR centres in Portugal 
were collected, based on the results of the national surveys 
on CR centres.11 All patients and CR centres were georefer-
enced according to the address using ArcGIS Online World 
Geocoding Service and Google Maps. The shortest road 
distance (in min) from the patients’ home to the nearest CR 
centre was calculated with ArcGIS V.10.4.1 and the Network 
Analyst extension, using an updated street network dataset 
provided by the Environmental Systems Research Institute.
statistical analysis
Continuous variables are described as mean and SD, 
whereas categorical variables are presented as absolute 
frequencies and percentages. Categorical and contin-
uous variables were compared using the χ2 test and the 
two-tailed Student’s t-test, as appropriate. The relation 
between patients’ characteristics and referral to CR was 
quantified through the calculation of ORs and 95%CIs, 
using unconditional logistic regression. Analyses were 
conducted for all patients and also stratified according to 
referral hospital. Starting from models with all candidate 
predictors (P value <0.15), based on results from bivariate 
analysis, independent predictors were identified after 
stepwise backward elimination (P value >0.05). All tests 
were two tailed, and a P value <0.05 was considered statis-
tically significant. Data were analysed using STATA V.11 
for Windows (StataCorp).
results
Among the 853 patients included in this study (mean 
age 63.5±12.9 years, 75.2% men), 489 (57.3%) were 
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from the Porto district, and 364 (42.7%) were from 
the NER of Portugal. Baseline characteristics are 
summarised in table 1. Compared with patients from 
the NER, those from Porto were more often male 
(79.1% vs 69.8%, P=0.002), younger (61.6 years vs 66.7 
years, P<0.001), more frequently employed (34.3% vs 
22.5%, P<0.001) and had higher levels of education 
(>4 schooling years: 50.5% vs 31.4%, P<0.001), social 
class (higher-middle/high: 9.0% vs 4.4%, P=0.001) and 
household income (>€1500: 19.0% vs 11.8%, P=0.014). 
Hypertension (72.5% vs 63.0%, P=0.003), dyslipidaemia 
(66.8% vs 58.7%, P=0.016), chronic heart failure (9.1% 
vs 4.7%, P=0.012) and impaired renal function at 
admission (9.9% vs 5.7%, P=0.022) were more frequent 
among patients who lived in the NER, whereas current 
smoking (38.5% vs 19.5%, P<0.001) and peripheral 
arterial disease (6.3% vs 3.3%, P=0.045) were more 
frequent among those who lived in Porto. The propor-
tion of patients discharged with a diagnosis of STEMI 
was lower in the NER than in the Porto district (33.2% 
vs 42.7%, P=0.005). Patients who lived in the NER were 
more likely to need a travel time to CR greater than 
30 min compared with those who lived in the Porto 
district (82.1% vs 5.3%, P<0.001). Travel times to the 
nearest CR centre are illustrated in figure 1B.
From the whole study sample, 158 patients from 
Porto district were referred by their physicians to attend 
a CR programme, whereas only 39 from the NER were 
referred (32.3% vs 10.7%, P<0.001) (figure 2). In both 
regions, patients who were male, younger, employed, 
with a white collar occupation, in higher social class, 
education and income and with health insurance 
coverage were more likely to be referred to a CR 
programme. Those who lived nearest to a CR centre, 
who were smokers and who were diagnosed with STEMI 
were also more likely to be referred to rehabilitation, 
whereas patients with comorbidities, anaemia at admis-
sion or impaired renal function were less likely to be 
referred to CR in both regions (table 2).
Predictors independently associated with CR referral are 
presented in table 3. In both regions, the probability of 
referral to CR decreased with age (Porto district: OR 0.95, 
95% CI 0.93 to 0.97 per year of age; NER: OR 0.95, 95% CI 
0.91 to 0.98 per year of age) and with longer travel times 
to CR centres (Porto district: OR 0.18, 95% CI 0.04 to 0.92; 
NER: OR 0.18, 95% CI 0.07 to 0.42). Patients living in the 
NER were less likely to be referred to CR, but the differences 
were not statistically significant, whereas longer travel times 
were negatively associated with referral. Among patients 
who lived in the Porto district, current smokers (OR 1.89, 
95% CI 1.12 to 3.20), in higher social class (lower-middle: 
OR 2.20, 95% CI 1.17 to 4.14; higher-middle: OR 2.30, 
95% CI 0.94 to 5.61), with health insurance coverage 
(OR 2.11, 95% CI 1.23 to 3.62) and those who underwent 
a percutaneous coronary intervention (PCI) (OR 3.24, 
95% CI 1.85 to 5.66) were more likely to be referred to 
CR, whereas those with comorbidities were less likely to be 
referred (1 comorbidity: OR 0.40, 95% CI 0.19 to 0.80; ≥2 
comorbidities: OR 0.22, 95% CI 0.05 to 1.01). In patients 
who lived in the NER, higher education (OR 3.10, 95% CI 
1.09 to 8.84) and higher household income (OR 4.83, 
95% CI 1.84 to 12.71) were independently associated with 
referral to CR.
Six months after hospital discharge, 128 patients from 
Porto and 26 from the NER reported participating in a CR 
programme (26.2% vs 7.1% of those eligible, P<0.001% and 
81.0% vs 66.7% of those referred, P<0.052) (figure 2). 
Among the 43 patients who did not enrol or complete 
the CR programme, the three major reasons reported for 
non-participation were the long time until a CR programme 
was available (33.3%), limited time available to participate 
(23.3%) and lack of perceived benefit (20.0%), according 
to patients from the Porto district, whereas most patients 
from the NER reported first the distance from home to the 
CR centre (84.6%), then the cost of CR (23.1%) and finally 
the limited time availability (7.7%).
DIscussIOn
Despite the proven benefits and the international recom-
mendations for CR after an ACS, our results showed that 
CR remains underused in Portugal, with major inequalities 
in access between regions. Following an ACS, one-third 
of the patients from the Porto district were referred to 
CR, whereas only 1 out of 10 patients from the NER were 
referred. Yet, of those who were referred, four-fifths from 
Porto and two-thirds from NER actually completed the CR 
programme, indicating that low participation was largely 
explained by low referral. Older patients with comorbid-
ities, with lower socioeconomic status and those living 
farther from a CR centre were less likely to be referred 
to CR, whereas patients with health insurance coverage, 
smokers and those who underwent a PCI were more likely 
to be referred.
The number of patients enrolled in CR programmes in 
Portugal in recent years is increasing;10 11 however, such 
programmes remain considerably underused, indicating 
that a large proportion of patients with CHD are missing 
the opportunity to benefit from CR. Several studies 
have shown that suboptimal referral patterns represent 
one of the major causes of poor participation in CR,15 
which is corroborated by our findings. Although in the 
Porto district the proportion of patients referred met 
the target set by the Portuguese Minister of Health, in 
the NER referral was far from reaching 30%.12 Studies 
conducted in other countries showed wide international 
variation,16 17 however, with much higher overall referral 
than in Portugal. A meta-analysis that included 241 613 
patients with CHD reported overall referrals of 45%,17 
similarly to those observed in the European Action on 
Secondary and Primary Prevention through Intervention 
to Reduce Events (EUROASPIRE) survey, which included 
13 935 patients with CHD, from 22 European countries.16 
Moreover, in the USA, data from the initiative Get with 
Guidelines, including 72 817 patients hospitalised after an 
MI, PCI or cardiac artery bypass graft, showed that 56% 
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Table 1 Baseline characteristics of the study population by region
Total* Porto district NER of Portugal
n (%)† n (%)† n (%)† P value
Total 853 (100.0) 489 (57.3) 364 (42.7) –
Males 641 (75.2) 387 (79.1) 254 (69.8) 0.002
Age (years), mean±SD 63.5±12.9 61.1 (12.6) 66.7 (12.5) <0.001
Partnered (vs unpartnered) 665 (78.3) 376 (77.5) 289 (79.4) 0.513
Schooling years >4 (vs ≤4) 359 (42.3) 245 (50.5) 114 (31.4) <0.001
Employed (vs unemployed/retired/disable) 268 (29.2) 180 (34.3) 88 (22.5) <0.001
Occupation
  Blue collar 460 (58.3) 260 (56.2) 200 (61.4) 0.054
  Lower white collar 184 (23.3) 105 (22.7) 79 (24.2)
  Upper white collar 145 (18.4) 98 (21.2) 47 (14.4)
Social class
  Low 282 (33.1) 138 (28.2) 144 (39.6) 0.001
  Lower-middle 285 (33.4) 172 (35.2) 113 (31.0)
  Higher-middle/high 60 (7.0) 44 (9.0) 16 (4.4)
  No response 226 (26.5) 135 (27.6) 91 (25.0)
  Monthly household income (€)
  ≤1500 575 (67.4) 321 (65.6) 254 (69.8) 0.014
  >1500 136 (15.9) 93 (19.0) 43 (11.8)
  No response 142 (16.7) 75 (15.3) 67 (18.4)
Health insurance coverage 205 (26.3) 110 (25.9) 95 (26.8) 0.763
Travel time to CR centre (min)
  <30 528 (61.9) 463 (94.7) 65 (17.9) <0.001
  ≥30 325 (38.1) 26 (5.3) 299 (82.1)
CV risk factors
  BMI (kg/m2), mean±SD 27.1±4.2 26.9±4.4 27.3±3.9 0.143
  Current smoker 257 (30.3) 186 (35.56) 7 (19.5) <0.001
  Hypertension 572 (67.1) 308 (63.0) 264 (72.5) 0.003
  Dyslipidaemia 530 (62.1) 287 (58.7) 243 (66.8) 0.016
  Diabetes 279 (32.7) 151 (30.9) 128 (35.2) 0.187
Comorbidities
  Previous MI 146 (17.1) 89 (18.1) 57 (15.7) 0.330
  Previous stroke 73 (8.6) 45 (9.2) 28 (7.7) 0.436
  Peripheral arterial disease 43 (5.0) 31 (6.3) 12 (3.3) 0.045
  Chronic renal failure 57 (6.7) 27 (5.5) 30 (8.2) 0.116
  Chronic heart failure 54 (6.6) 22 (4.7) 32 (9.1) 0.012
  Number of comorbidities
  0 562 (68.6) 323 (69.2) 239 (67.9) 0.795
  1 175 (21.4) 96 (20.6) 79 (22.4)
  ≥2 82 (10.0) 48 (10.3) 34 (9.7)
Clinical characteristics at admission
  Heart rate (bpm), mean±SD 77.7±19.3 77.9±20.0 77.2±17.9 0.700
  Systolic blood pressure (mm Hg), mean±SD 140.3±29.1 141.3±29.0 138.3±29.4 0.283
  Anaemia‡ 161 (18.9) 83 (17.0) 78 (21.4) 0.100
  Impaired renal function§ 64 (7.5) 28 (5.7) 36 (9.9) 0.022
  Killip class III–IV 38 (4.5) 19 (3.9) 19 (5.2) 0.350
Continued
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Total* Porto district NER of Portugal
n (%)† n (%)† n (%)† P value
Moderate–severe LVSD 249 (30.0) 146 (29.9) 103 (30.0) 0.973
Medical procedures
  PCI 544 (63.8) 310 (63.4) 234 (64.3) 0.789
  CABG 135 (15.8) 85 (17.4) 50 (13.7) 0.149
  STEMI (vs NSTEACS) 330 (38.7) 209 (42.7) 121 (33.2) 0.005
*Total may not add to 853 due to missing data.
†Results are presented as n (%), except if otherwise specified.
‡Anaemia was defined as haemoglobin level ≤12 g/dL for women and ≤13 g/dL for men.
§Impaired renal function was defined as serum creatinine level ≥1.5 mg/dL.
BMI, body mass index; CABG, cardiac artery bypass graft; CR, cardiac rehabilitation; CV, cardiovascular; LVSD, left ventricular 
systolic dysfunction; MI, myocardial infarction; NER, north-east region; NSTEACS, non-ST-elevation acute coronary syndrome; PCI, 
percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction.
Table 1 Continued 
Figure 2 Referral and participation rates to CR according to 
region. CR, cardiac rehabilitation.
of those eligible were referred,18 whereas recent results 
of a national survey in England showed 81.5% of patients 
referred to CR between 2012 and 2015.19
Previous research has demonstrated that there are wide 
inequalities in CR referral against women, elders and 
deprived socioeconomic populations.16–18 20 21 In fact, we 
found that older patients were less likely to be referred 
to CR, but no association was found regarding sex. In 
addition to higher income and education being associ-
ated with referral in the NER, our results also showed that 
patients in the lower social class and with multiple comor-
bidities were less likely to be referred in the Porto district, 
reiterating the treatment-risk paradox,22 23 such that 
patients at high-risk who may benefit the most from CR 
are less likely to access it. These findings are particularly 
worrisome in the current context of population ageing, 
with an increasing number of comorbidities. Although 
evidence shows that all patients with CHD benefit from 
participation in CR, regardless of age or medical comor-
bidity burden,24 physicians may perceive these disadvan-
taged groups as less likely to take advantage of CR. Several 
studies that analysed physician factors associated with CR 
referral pointed out the perceived benefit of CR as one 
of the most relevant factors affecting referral.25 26 There-
fore, increasing physicians’ awareness about the benefits 
of CR in higher risk populations is warranted. Besides the 
importance of physicians’ endorsement, implementing 
systematic referral approaches in which eligible patients 
are automatically identified and referred to CR have been 
shown to have a significant impact on increasing referral 
and enrolment.27 Grace et al demonstrated that using a 
combined automatic referral with patient discussion 
can achieve referral of over 85% and enrolment around 
74%.28 Moreover, these strategies have been described as 
having the potential to mitigate disparities in access to CR, 
namely among patients with lower socioeconomic status.29
Our results also showed that patients who live farther 
from a CR centre were less likely to be referred, in accor-
dance with previous studies that described geographical 
accessibility, measured by distance, transportation, travel 
time or costs, as an important barrier to CR referral 
and participation.25 30 The 30 min travel time threshold 
has often been used to define accessible healthcare 
services;31 32 however, a study conducted by Brual et al that 
investigated the travel time threshold affecting specifi-
cally CR use found that patients who have a travel time to 
CR greater than 60 min were less likely to be referred and 
also to be enrolled in a programme.30 In our study, almost 
half of the patients from the NER lived beyond 60 min 
of the CR centre compared with a residual proportion in 
the Porto district, indicating that patients from the NER 
face higher geographical barriers to access CR services 
than patients living in the Porto district. To overcome 
geographical barriers in access to CR, alternative delivery 
models, such as home-based programmes, should be 
considered, particularly for those patients in rural areas. 
A recent systematic review of data from 17 randomised 
trials,33 which included 2172 patients from 10 countries, 
compared the effectiveness of home-based to supervised 
centre-based CR and found similar benefits in terms of 
mortality, morbidity, quality of life and modifiable risk 
factors.
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Table 2 Referral to CR after an ACS according to the patients’ characteristics by region
All Porto district NER of Portugal
n (%)* P value n (%)* P value n (%)* P value
Total 197 (23.1) – 158 (32.3) – 39 (10.7) –
Sex
  Female 30 (14.2) <0.001 25 (24.5) 0.058 5 (4.6) 0.012
  Male 167 (26.1) 133 (34.5) 34 (13.4)
Age (years), mean±SD 54.6±10.5 <0.001 54.4±10.3 <0.001 55.6±11.0 <0.001
Marital status
  Partnered 158 (23.8) 0.466 123 (32.7) 0.906 35 (12.1) 0.063
  Unpartnered 39 (21.2) 35 (32.1) 4 (5.3)
Schooling years
  ≤4 57 (11.7) <0.001 49 (20.4) <0.001 8 (3.2) <0.001
  >4 140 (39.0) 109 (44.5) 31 (27.2)
Employment status
  Employed 115 (44.2) <0.001 94 (52.2) 22 (25.0)
  Unemployed/retired/disable 82 (13.8) 69 (20.0) <0.001 19 (6.3) <0.001
Occupation
  Blue collar 90 (19.6) <0.001 76 (29.2) 0.006 14 (7.0) 0.002
  Lower white collar 36 (25.0) 33 (31.4) 13 (16.5)
  Upper white collar 57 (39.3) 46 (46.9) 11 (23.4)
Social class
  Low 42 (14.9) <0.001 34 (24.6) <0.001 8 (5.6) 0.030
  Lower-middle 85 (29.8) 73 (42.4) 12 (10.6)
  Higher-middle/high 25 (41.7) 21 (47.7) 4 (25.0)
  No response 45 (19.9) 30 (22.2) 15 (16.5)
Monthly household income (€)
  ≤1500 110 (19.1) <0.001 90 (28.0) <0.001 20 (7.9) <0.001
  >1500 67 (49.3) 50 (53.8) 17 (39.5)
  No response 20 (14.1) 18 (24.0) 2 (3.0)
Health insurance coverage
  No 111 (19.3) <0.001 90 (28.6) <0.001 21 (8.1) 0.008
  Yes 71 (34.6) 54 (37.4) 17 (17.9)
Travel time to CR centre (min)
  <30 172 (32.6) <0.001 155 (33.5) 0.020 17 (26.2) <0.001
  ≥30 25 (7.7) 3 (11.5) 22 (7.4)
Risk factors
  BMI (kg/m2), mean±SD 26.8±4.1 0.412 26.7±4.2 0.582 27.4±3.5 0.887
  Current smoker—no 88 (14.9) <0.001 68 (22.4) <0.001 20 (6.8) <0.001
  Yes 108 (42.0) 89 (45.9) 19 (26.8)
  Hypertension—no 97 (34.5) <0.001 75 (41.4) 0.001 22 (22.0) <0.001
  Yes 100 (17.5) 83 (27.0) 17 (6.4)
  Dyslipidaemia—no 90 (27.9) 0.010 78 (38.6) 0.012 12 (9.9) 0.620
  Yes 107 (20.2) 80 (27.9) 27 (11.1)
  Diabetes—no 154 (26.8) <0.001 124 (36.7) 0.002 30 (76.9) 0.094
  Yes 43 (15.4) 34 (22.5) 9 (7.0)
Comorbidities
  Previous MI—no 180 (25.5) <0.001 143 (35.8) 0.001 37 (12.1) 0.055
Continued
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All Porto district NER of Portugal
n (%)* P value n (%)* P value n (%)* P value
  Yes 17 (11.6) 15 (16.9) 2 (3.5)
  Previous stroke—no 189 (24.2) 0.010 152 (34.2) 0.004 37 (11.0) 0525
  Yes 8 (11.0) 6 (13.3) 2 (7.1)
  Peripheral arterial disease—no 193 (23.8) 0.028 156 (34.1) 0.001 37 (10.5) 0498
  Yes 4 (9.3) 2 (6.5) 2 (16.7)
  Chronic renal failure— no 195 (24.5) <0.001 156 (33.8) 0.004 39 (11.7) 0.048
  Yes 2 (3.5) 2 (7.4) 0 (0.0)
  Chronic heart failure—no 185 (24.2) <0.001 150 (33.7) 0.001 35 (10.9) 0.049
  Yes 0 (0.0) 0 (0.0) 0 (0.0)
  Number of comorbidities
  0 163 (29.0) <0.001 131 (40.6) <0.001 32 (13.4) 0.005
  1 17 (9.7) 16 (16.7) 1 (1.3)
  ≥2 5 (6.1) 3 (6.3) 2 (5.9)
Clinical characteristics at admission
  Heart rate (bpm), mean±SD 77.1±17.5 0.786 77.2±17.9 0.700 76.7±15.7 0.898
  SBP (mm Hg), mean±SD 139.0±29.0 0.198 138.3±29.4 0.283 141.7±27.5 0.840
  Anaemia†—no 180 (26.0) <0.001 144 (35.5) 0.001 36 (12.6) 0.027
  Yes 17 (10.6) 14 (16.9) 3 (3.9)
  Impaired renal function‡—no 194 (25.6) <0.001 155 (33.6) 0.012 39 (11.9) 0.029
  Yes 2 (4.7) 3 (10.7) 0 (0.0)
  Killip class
  I–II 190 (23.3) 0.484 153 (32.6) 0.569 37 (10.7) 0.978
  III–IV 7 (18.4) 2 (26.3) 2 (10.5)
Moderate–severe LVSD—no 146 (25.1) 0.153 115 (33.6) 0.367 31 (12.9) 0.168
  Yes 51 (20.5) 43 (29.5) 8 (7.8)
Medical procedures
  PCI—no 41 (13.3) <0.001 30 (16.8) <0.001 11 (8.5) 0.300
  Yes 156 (28.7) 128 (41.3) 28 (12.0)
  CABG—no 176 (24.5) 0.023 146 (36.1) <0.001 30 (9.6) 0.073
  Yes 21 (15.6) 12 (14.1) 9 (18.0)
Type of ACS
  STEMI 104 (31.5) <0.001 84 (40.2) 0.001 20 (16.5) 0.011
  NSTEACS 93 (17.9) 74 (26.4) 19 (7.8)
*Results are presented as n(%), except if otherwise specified.
†Anaemia was defined as haemoglobin level ≤12 g/dL for women and ≤13 g/dL for men.
‡Impaired renal function was defined as serum creatinine level ≥1.5 mg/dL.
ACS, acute coronary syndrome; BMI, body mass index; CABG, cardiac artery bypass graft; CR, cardiac rehabilitation; LVSD, left 
ventricular systolic dysfunction; MI, myocardial infarction; NER, north-east region; NSTEACS, non-ST-elevation acute coronary 
syndrome; PCI, percutaneous coronary intervention; SBP, systolic blood pressure; STEMI, ST-elevation myocardial infarction.
Table 2 Continued 
Consistent with the results reported in the EURO-
ASPIRE III,16 our study showed that a high proportion of 
referred patients from the Porto district completed the 
CR programme. Nonetheless, in the NER, the propor-
tion of those failing to complete the programme (33.3%) 
contributed to the underuse of CR. According to patients 
in the NER region, the main barriers to their partici-
pation in CR were distance to the centre and financial 
costs, in line with previous research that identified those 
as important predictors of non-participation.34 35 The 
geographic maldistribution of CR centres is a well-known 
barrier to access CR in Portugal, with significantly fewer 
centres in inland areas compared with the coast and in the 
south compared with the north.10 11 In the Porto district, 
there were seven centres, either public hospital-based or 
private community-based, whereas in the NER, there was 
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Table 3 Predictors of CR referral among patients following an acute coronary syndrome by region
Adjusted OR (95% CI)
All Porto district NER of Portugal
Region*
  Porto district 1 – –
  NER of Portugal 0.93 (0.48 to 1.79) – –
Sex*
  Female 1 1 1
  Male 0.81 (0.47 to 1.38) 1.01 (0.53 to 1.93) 1.76 (0.58 to 5.38)
Age (years) 0.96 (0.94 to 0.99) 0.95 (0.93 to 0.97) 0.95 (0.91 to 0.98)
Schooling years (years)
  ≤4 1 – 1
  >4 1.72 (1.07 to 2.76) – 3.10 (1.09 to 8.84)
Monthly household income (€)
  ≤1500 1 – 1
  >1500 2.79 (1.65 to 4.72) – 4.83 (1.84 to 12.71)
  No response 0.85 (0.46 to 1.58) – 0.49 (0.10 to 2.40)
Social class
  Low – 1 –
  Lower-middle – 2.20 (1.17 to 4.14) –
  Higher-middle/high – 2.30 (0.94 to 5.61) –
  No response – 1.02 (0.50 to 2.08) –
Health insurance coverage
  No – 1 –
  Yes – 2.11 (1.23 to 3.62) –
Travel time to CR centre (min)
  <30 1 1 1
  ≥30 0.19 (0.09 to 0.39) 0.18 (0.04 to 0.92) 0.18 (0.07 to 0.42)
Current smoker
  No 1 1 –
  Yes 1.75 (1.13 to 2.72) 1.89 (1.12 to 3.20) –
Number of comorbidities
  0 1 1 –
  1 0.37 (0.20 to 0.68) 0.40 (0.19 to 0.80) –
  ≥2 0.40 (0.15 to 0.12) 0.22 (0.05 to 1.01) –
PCI
  No 1 1 –
  Yes 3.00 (1.87 to 4.80) 3.24 (1.85 to 5.66) –
Impaired renal function†
  No 1 – –
  Yes 0.21 (0.05 to 0.85) – –
All independent variables were included in the model as categorical, except age (continuous).
Dash line - this variable was no included in the model.
*Variables were forced into models.
†Impaired renal function was defined as serum creatinine level ≥1.5 mg/dL.
CR, cardiac rehabilitation; NER, north-east region; PCI, percutaneous cardiac intervention.
only one private community-based centre. These inequal-
ities are even more prominent because the costs of public 
centres are partially supported by the NHS, whereas CR 
programmes running in private centres are not funded 
by the government. During the study period, however, 
the private centre in the NER was supported by a specific 
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protocol established with the government between 2012 
and 2015, covering the costs of CR. Even so, costs were 
still mentioned as an important barrier to participation 
which may be explained by the indirect financial costs 
of participating in CR, namely the high transportation 
costs especially in more remote areas and for patients 
of lower socioeconomic status. Furthermore, patients 
from the Porto district identified delays to initiate the CR 
programme and lack of awareness of the benefits of CR 
as the main barriers, whereas limited time availability was 
identified by patients from both regions. In line with our 
results, a review that included 34 qualitative studies iden-
tified as key the physical barriers, such as lack of trans-
port, financial cost or work commitment, and personal 
barriers, including embarrassment about participation or 
lack of perceived benefit of CR.34
limitations
This study includes a multitude of factors that give 
important insights about access to CR in Portugal, 
although the findings should be interpreted in the 
context of the following potential limitations. First, 
recall bias may be at play as a result of the amount of 
time that elapsed between discharge and completion 
of the 6-month follow-up. However, using information 
about CR use based on patients’ self-report may be 
more accurate than using physicians’ chart. Previous 
research has shown that despite high concordance 
between self-reported and chart report, physicians’ 
referral may be influenced by the barriers identified 
by patients during the CR referral discussion, which 
may result in lower referral reporting in chart.25 Lastly, 
our results may not be generalised to other settings 
with different characteristics, although the study was 
conducted in two hospitals, one university hospital and 
one tertiary-level hospital, allowing the comparison of 
different urban and rural settings.
cOnclusIOn
CR remains insufficiently implemented in Portugal, 
with major inequalities between regions. Our results 
show clear differences in access among vulnerable 
subpopulations, such as rural populations, elders, 
high-risk patients and socioeconomically deprived. 
The achievement of optimal CR use requires a multi-
level approach addressing barriers related to health-
care system, providers and patients in order to improve 
provision, referral and participation.
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